4.6 Article

Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study

Journal

BRITISH JOURNAL OF DERMATOLOGY
Volume 170, Issue 2, Pages 445-453

Publisher

WILEY-BLACKWELL
DOI: 10.1111/bjd.12695

Keywords

-

Categories

Funding

  1. Bayer HealthCare, AG
  2. KYTHERA Biopharmaceuticals, Inc.

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available